{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:22:39Z","timestamp":1759882959403,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04575-2","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:19:11Z","timestamp":1747739951000},"page":"3709-3712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic goals for mitigating chronic kidney disease progression in kidney transplant recipients: a 2024 update"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9310-5463","authenticated-orcid":false,"given":"Mois\u00e9s","family":"Carminatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-323X","authenticated-orcid":false,"given":"Helio","family":"Tedesco-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8603-1331","authenticated-orcid":false,"given":"Helady","family":"Sanders-Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"4575_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/nep.13483","volume":"24","author":"M Carminatti","year":"2019","unstructured":"Carminatti M, Tedesco-Silva H, Fernandes NMS, Sanders-Pinheiro H (2019) Chronic kidney disease progression in kidney transplant recipients: a focus on traditional risk factors. Nephrology (Carlton) 24:141\u2013147","journal-title":"Nephrology (Carlton)"},{"key":"4575_CR2","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.2215\/CJN.15070920","volume":"16","author":"HN Ibrahim","year":"2021","unstructured":"Ibrahim HN, Murad DN, Knoll GA (2021) Thinking outside the box: novel kidney protective strategies in kidney transplantation. Clin J Am Soc Nephrol 16:1890\u20131897","journal-title":"Clin J Am Soc Nephrol"},{"key":"4575_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","volume":"9","author":"Kidney Disease. Improving global outcomes (KDIGO) transplant work group","year":"2009","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) transplant work group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9:S1\u2013S155","journal-title":"Am J Transplant"},{"key":"4575_CR4","doi-asserted-by":"publisher","first-page":"1185001","DOI":"10.3389\/fcvm.2023.1185001","volume":"10","author":"CS Kim","year":"2023","unstructured":"Kim CS, Oh TR, Suh SH et al (2023) Uncontrolled hypertension is associated with increased risk of graft failure in kidney transplant recipients: a nationwide population-based study. Front Cardiovasc Med 10:1185001","journal-title":"Front Cardiovasc Med"},{"key":"4575_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1053\/j.ajkd.2015.11.026","volume":"67","author":"LV De Vries","year":"2016","unstructured":"De Vries LV, Dobrowolski LC, van den Bosch JJ et al (2016) Effects of dietary sodium restriction in kidney transplant recipients treated with renin-angiotensin-aldosterone system blockade: a randomized clinical trial. Am J Kidney Dis 67:936\u2013944","journal-title":"Am J Kidney Dis"},{"key":"4575_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1681\/ASN.2014080834","volume":"26","author":"MR Weir","year":"2015","unstructured":"Weir MR, Burgess ED, Cooper JE et al (2015) Assessment and management of hypertension in transplant patients. J Am Soc Nephrol 26:1248\u20131260","journal-title":"J Am Soc Nephrol"},{"key":"4575_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5500\/wjt.v12.i8.211","volume":"12","author":"ME Alexandrou","year":"2022","unstructured":"Alexandrou ME, Ferro CJ, Boletis I, Papagianni A, Sarafidis P (2022) Hypertension in kidney transplant recipients. World J Transplant 12:211\u2013222","journal-title":"World J Transplant"},{"key":"4575_CR8","first-page":"84","volume":"45","author":"RNS Rebelo","year":"2023","unstructured":"Rebelo RNS, Rodrigues CIS (2023) Arterial hypertension in kidney transplantation: huge importance, but few answers. Braz J Nephrol 45:84\u201394","journal-title":"Braz J Nephrol"},{"key":"4575_CR9","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1097\/TP.0000000000004228","volume":"106","author":"JH Lim","year":"2022","unstructured":"Lim JH, Kwon S, Jeon Y et al (2022) The efficacy and safety of SGLT2 inhibitor in diabetic kidney transplant recipients. Transplantation 106:e404\u2013e412","journal-title":"Transplantation"},{"key":"4575_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","volume":"5","author":"GD Lopaschuk","year":"2020","unstructured":"Lopaschuk GD, Verma S (2020) Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review. JACC Basic Transl Sci 5:632\u2013644","journal-title":"JACC Basic Transl Sci"},{"issue":"4S","key":"4575_CR11","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4S):S117\u2013S314","journal-title":"Kidney Int"},{"key":"4575_CR12","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1038\/s41467-024-54171-8","volume":"15","author":"JY Sheu","year":"2024","unstructured":"Sheu JY, Chang LY, Chen JY et al (2024) The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients. Nat Commun 15:10043","journal-title":"Nat Commun"},{"key":"4575_CR13","doi-asserted-by":"publisher","first-page":"204201882210900","DOI":"10.1177\/20420188221090001","volume":"13","author":"A Ujjawal","year":"2022","unstructured":"Ujjawal A, Schreiber B, Verma A (2022) Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence? Ther Adv Endocrinol Metab 13:20420188221090000","journal-title":"Ther Adv Endocrinol Metab"},{"key":"4575_CR14","doi-asserted-by":"publisher","first-page":"1332397","DOI":"10.3389\/fneph.2024.1332397","volume":"4","author":"E Polychronopoulou","year":"2024","unstructured":"Polychronopoulou E, Bourdon F, Teta D (2024) SGLT2 inhibitors in diabetic and non-diabetic kidney transplant recipients: current knowledge and expectations. Front Nephrol 4:1332397","journal-title":"Front Nephrol"},{"key":"4575_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/ndt\/gfy365","volume":"34","author":"M Tsujita","year":"2019","unstructured":"Tsujita M, Kosugi T, Goto N et al (2019) The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial. Nephrol Dial Transplant 34:1409\u20131416","journal-title":"Nephrol Dial Transplant"},{"key":"4575_CR16","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.21037\/atm-22-5897","volume":"10","author":"H Li","year":"2022","unstructured":"Li H, Hu SM, Li YM et al (2022) Beneficial effect of roxadustat on early posttransplant anemia and iron utilization in kidney transplant recipients: a retrospective comparative cohort study. Ann Transl Med 10:1360","journal-title":"Ann Transl Med"},{"key":"4575_CR17","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfae075","volume":"39","author":"S Stoumpos","year":"2024","unstructured":"Stoumpos S, Crowe K, Sarafidis P et al (2024) Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association. Nephrol Dial Transplant 39:1710\u20131730","journal-title":"Nephrol Dial Transplant"},{"key":"4575_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.ajkd.2020.02.439","volume":"76","author":"SC Palmer","year":"2020","unstructured":"Palmer SC, Mavridis D, Johnson DW, Tonelli M, Ruospo M, Strippoli GFM (2020) Comparative effectiveness of calcimimetic agents for secondary hyperparathyroidism in adults: a systematic review and network meta-analysis. Am J Kidney Dis 76:321\u2013330","journal-title":"Am J Kidney Dis"},{"key":"4575_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2215\/CJN.03410321","volume":"17","author":"P Khairallah","year":"2022","unstructured":"Khairallah P, Nickolas PL (2022) Bone and mineral disease in kidney transplant recipients. Clin J Am Soc Nephrol 17:121\u2013130","journal-title":"Clin J Am Soc Nephrol"},{"key":"4575_CR20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/ijms25031859","volume":"25","author":"JW Teh","year":"2024","unstructured":"Teh JW, Mac Gearailt C, Lappin DWP (2024) Post-transplant bone disease in kidney transplant recipients: diagnosis and management. Int J Mol Sci 25:1859","journal-title":"Int J Mol Sci"},{"key":"4575_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ndt\/gfad258","volume":"39","author":"A Sharif","year":"2024","unstructured":"Sharif A, Chakkera H, De Vries APJ et al (2024) International consensus on post-transplantation diabetes mellitus. Nephrol Dial Transplant 39:531\u2013549","journal-title":"Nephrol Dial Transplant"},{"key":"4575_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000514288","volume":"145","author":"AE Rodr\u00edguez-Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez-Rodr\u00edguez AE, Porrini E, Hornum M et al (2021) Post-transplant diabetes mellitus and prediabetes in renal transplant recipients: an update. Nephron 145:317\u2013329","journal-title":"Nephron"},{"key":"4575_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1159\/000508476","volume":"45","author":"D Gojowy","year":"2020","unstructured":"Gojowy D, Skiba K, Bartmanska M, Kolonko A, Wiecek A, Adamczak M (2020) Is metabolic acidosis a novel risk factor for a long-term graft survival in patients after kidney transplantation? Kidney Blood Press Res 45:702\u2013712","journal-title":"Kidney Blood Press Res"},{"key":"4575_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(22)02606-X","volume":"401","author":"N Mohebbi","year":"2023","unstructured":"Mohebbi N, Ritter A, Wiegand A et al (2023) Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial. Lancet 401:557\u2013567","journal-title":"Lancet"},{"key":"4575_CR25","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","volume":"5","author":"H Holdaas","year":"2005","unstructured":"Holdaas H, Fellstr\u00f6m B, Cole E et al (2005) Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. Am J Transplant 5:2929\u20132936","journal-title":"Am J Transplant"},{"key":"4575_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/ajt.13000","volume":"15","author":"ED Kim","year":"2020","unstructured":"Kim ED, Famure O, Kim ED, Famure O, Li Y, Kim SJ (2020) Uric acid and the risk of graft failure in kidney transplant recipients: a re-assessment. Am J Transplant 15:482\u2013488","journal-title":"Am J Transplant"},{"key":"4575_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/TP.0000000000003214","volume":"105","author":"H Sanders-Pinheiro","year":"2021","unstructured":"Sanders-Pinheiro H, Colugnati FAB, Denhaerynck K et al (2021) Multilevel correlates of immunosuppressive nonadherence in kidney transplant patients: the multicenter ADHERE BRAZIL study. Transplantation 105:255\u2013266","journal-title":"Transplantation"},{"key":"4575_CR28","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.kint.2023.05.010","volume":"104","author":"MA Josephson","year":"2023","unstructured":"Josephson MA, Becker Y, Budde K et al (2023) Challenges in the management of the kidney allograft: from decline to failure: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 104:1076\u20131091","journal-title":"Kidney Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04575-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:35:26Z","timestamp":1759844126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04575-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4575"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04575-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}